PKN3 and neoplasm: Santel et al. have suggested that knockdown of PKN3 by giving the siRNA drug, Atu027, into whole body significantly suppressed tumor metastasis in mouse model37, which suggests the potential role of host PKN3 in tumor progression, whereas clear deprivation of the effect of siRNA on tumor-derived PKN3 seems to be impossible in this system.